Both in Pharmaceuticals
Rocket Pharmaceuticals vs Q32 Bio
Over the past year RCKT returned −29.5% and QTTB returned +240.9%; their daily moves had a correlation of 0.06.
RCKT −29.5% QTTB +240.9%Growth of $1, one year, split-adjusted
| Metric | RCKT | QTTB |
|---|---|---|
| Price | $2.51 | $8.76 |
| Market cap | $275.5M | $260.8M |
| Today | +1.62% | +0.57% |
| 1 month | −3.8% | +4.7% |
| 6 months | −29.1% | +70.4% |
| Year to date | −28.5% | +163.9% |
| 1 year | −33.4% | +211.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 7.7× |
| Price / sales | — | 4.9× |
| Net cash | $262.5M | $106.3M |
| Dividend yield | — | — |
| Volatility (60d) | 66.3% | 62.7% |
| Short % of float | 19.2% | 32.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).